HR 2520 RDS 
cost of transplants from unrelated donors and 
the effectiveness of Program operations; and 
‘‘(K) assist qualified cord blood stem cell 
banks in the Program in accordance with para-
graph (3). 
Subsections (c) through (e) apply with respect to 
each entity awarded a contract under this section 
with respect to bone marrow. 
‘‘(2) CORD BLOOD FUNCTIONS.—With respect 
to cord blood, the Program shall— 
‘‘(A) operate a system for identifying, 
matching, and facilitating the distribution of 
donated cord blood units that are suitably 
matched to candidate patients and meet all ap-
plicable Federal and State regulations (includ-
ing informed consent and Food and Drug Ad-
ministration regulations) from a qualified cord 
blood stem cell bank; 
‘‘(B) allow transplant physicians, other ap-
propriate health care professionals, and patients 
to search by means of electronic access all avail-
able cord blood units listed in the Program; 
‘‘(C) allow transplant physicians and other 
appropriate health care professionals to ten-
HR 2520 RDS 
tatively reserve a cord blood unit for transplan-
tation; 
‘‘(D) support studies and demonstration 
and outreach projects for the purpose of in-
creasing cord blood donation to ensure a geneti-
cally diverse collection of cord blood units; and 
‘‘(E) coordinate with the Secretary to 
carry out information and educational activities 
for the purpose of increasing cord blood dona-
tion and promoting the availability of cord 
blood units as a transplant option. 
‘‘(3) SINGLE POINT OF ACCESS.—If the Sec-
retary enters into a contract with more than one en-
tity to perform the functions outlined in this sub-
section, the Secretary shall establish procedures to 
ensure that health care professionals and patients 
are able to obtain, consistent with the functions de-
scribed in paragraphs (1)(A) and (2)(A), cells from 
adult donors and cord blood units through a single 
point of access. 
‘‘(4) DEFINITION.—The term ‘qualified cord 
blood stem cell bank’ means a cord blood stem cell 
bank that— 
‘‘(A) has obtained all applicable Federal 
and State licenses, certifications, registrations
HR 2520 RDS 
(including pursuant to the regulations of the 
Food and Drug Administration), and other au-
thorizations required to operate and maintain a 
cord blood stem cell bank; 
‘‘(B) has implemented donor screening, 
cord blood collection practices, and processing 
methods intended to protect the health and 
safety of donors and transplant recipients to 
improve transplant outcomes, including with re-
spect to the transmission of potentially harmful 
infections and other diseases; 
‘‘(C) is accredited by an accreditation body 
recognized pursuant to a public process by the 
Secretary; 
‘‘(D) has established a system of strict 
confidentiality to protect the identity and pri-
vacy of patients and donors in accordance with 
existing Federal and State law; and 
‘‘(E) has established a system for encour-
aging donation by a genetically diverse group of 
donors.’’; 
(4) in subsection (c)— 
(A) in paragraph (1), by striking ‘‘The 
Registry shall carry out a program for the re-
cruitment’’ and inserting ‘‘With respect to bone
HR 2520 RDS 
marrow, the Program shall carry out a program 
for the recruitment’’; 
(B) in paragraph (2)(A)— 
(i) in the matter preceding clause (i), 
by striking the first sentence and inserting 
‘‘In carrying out the program under para-
graph (1), the Program shall carry out in-
formational and educational activities, in 
coordination with organ donation public 
awareness campaigns operated through the 
Department of Health and Human Serv-
ices, for purposes of recruiting individuals 
to serve as donors of bone marrow and 
shall test and enroll with the Program po-
tential donors.’’; and 
(ii) in clause (ii), by striking ‘‘, in-
cluding providing updates’’; and 
(C) in paragraph (3), by striking ‘‘the 
availability, as a potential treatment option, of 
receiving a transplant of bone marrow from an 
unrelated donor’’ and inserting ‘‘transplants 
from unrelated donors as a treatment option 
and resources for identifying and evaluating 
other therapeutic alternatives’’; 
(5) in subsection (d)—
HR 2520 RDS 
(A) in paragraph (1), by striking ‘‘The 
Registry shall’’ and inserting ‘‘With respect to 
bone marrow, the Program shall’’; 
(B) in paragraph (2)(C), by inserting ‘‘and 
assist with information regarding third party 
payor matters’’ after ‘‘ongoing search for a 
donor’’; 
(C) in subparagraphs (C), (D), and (E) of 
paragraph (2), by striking the term ‘‘subsection 
(b)(1)’’ each place such term appears and in-
serting ‘‘subsection (b)(1)(A)’’; 
(D) in paragraph (2)(F)— 
(i) by redesignating clause (v) as 
clause (vi); and 
(ii) by inserting after clause (iv) the 
following: 
‘‘(v) Information concerning issues 
that patients may face after a transplant 
regarding continuity of care and quality of 
life.’’; and 
(E) in paragraph (3)(B), by striking ‘‘Of-
fice may’’ and inserting ‘‘Office shall’’; 
(6) in the matter preceding paragraph (1) in 
subsection (e), by striking ‘‘the Secretary shall’’ and
HR 2520 RDS 
inserting ‘‘with respect to bone marrow, the Sec-
retary shall’’; 
(7) by amending subsection (f) to read as fol-
lows: 
‘‘(f) COMMENT PROCEDURES.—The Secretary shall 
establish and provide information to the public on proce-
dures under which the Secretary shall receive and consider 
comments from interested persons relating to the manner 
in which the Program is carrying out the duties of the 
Program.’’; 
(8) by amending subsection (g) to read as fol-
lows: 
‘‘(g) CONSULTATION.—In developing policies affect-
ing the Program, the Secretary shall consult with the Ad-
visory Council, the Department of Defense Marrow Donor 
Recruitment and Research Program operated by the De-
partment of the Navy, and the board of directors of each 
entity awarded a contract under this section.’’; 
(9) in subsection (h)— 
(A) by striking ‘‘APPLICATION.—’’ and in-
serting ‘‘CONTRACTS.—’’; 
(B) by striking ‘‘To be eligible’’ and insert-
ing the following: 
‘‘(1) APPLICATION.—To be eligible’’; and 
(C) by adding at the end the following:
HR 2520 RDS 
‘‘(2) CONSIDERATIONS.—In awarding contracts 
under this section, the Secretary shall give substan-
tial weight to the continued safety of donors and pa-
tients and other factors deemed appropriate by the 
Secretary.’’; and 
(10) by striking subsection (l). 
(b) STEM CELL THERAPEUTIC OUTCOMES DATA-
BASE.—Section 379A of the Public Health Service Act (42 
U.S.C. 274l) is amended to read as follows: 
‘‘SEC. 379A. STEM CELL THERAPEUTIC OUTCOMES DATA-
BASE. 
‘‘(a) ESTABLISHMENT.—The Secretary shall by con-
tract establish and maintain a scientific database of infor-
mation relating to patients who have been recipients of 
stem cell therapeutics product (including bone marrow, 
cord blood, or other such product) from a biologically un-
related donor. 
‘‘(b) INFORMATION.—The outcomes database shall 
include information with respect to patients described in 
subsection (a), transplant procedures, and such other in-
formation as the Secretary determines to be appropriate, 
to conduct an ongoing evaluation of the scientific and clin-
ical status of transplantation involving recipients of bone 
marrow from biologically unrelated donors and recipients 
of a stem cell therapeutics product.
HR 2520 RDS 
‘‘(c) ANNUAL REPORT ON PATIENT OUTCOMES.— 
The Secretary shall require the entity awarded a contract 
under this section to submit to the Secretary an annual 
report concerning patient outcomes with respect to each 
transplant center, based on data collected and maintained 
by the entity pursuant to this section. 
‘‘(d) PUBLICLY AVAILABLE DATA.—The outcomes 
database shall make relevant scientific information not 
containing individually identifiable information available 
to the public in the form of summaries and data sets to 
encourage medical research and to provide information to 
transplant programs, physicians, patients, entities award-
ed a contract under section 379 donor registries, and cord 
blood stem cell banks.’’. 
(c) DEFINITIONS.—Part I of title III of the Public 
Health Service Act (42 U.S.C. 274k et seq.) is amended 
by inserting after section 379A the following: 
‘‘SEC. 379A–1. DEFINITIONS. 
‘‘In this part: 
‘‘(1) The term ‘Advisory Council’ means the ad-
visory council established by the Secretary under 
section 379(a)(1). 
‘‘(2) The term ‘bone marrow’ means the cells 
found in adult bone marrow and peripheral blood.
HR 2520 RDS 
‘‘(3) The term ‘outcomes database’ means the 
database established by the Secretary under section 
379A. 
‘‘(4) The term ‘Program’ means the C.W. Bill 
Young Cell Transplantation Program established 
under section 379.’’. 
(d) AUTHORIZATION OF APPROPRIATIONS.—Section 
379B of the Public Health Service Act (42 U.S.C. 274m) 
is amended to read as follows: 
‘‘SEC. 379B. AUTHORIZATION OF APPROPRIATIONS. 
‘‘(a) IN GENERAL.—For the purpose of carrying out 
this part, there are authorized to be appropriated 
$28,000,000 for fiscal year 2006 and $32,000,000 for 
each of fiscal years 2007 through 2010. 
‘‘(b) EMERGENCY CONTINGENCY RESPONSE CAPA-
BILITIES.—In addition to the amounts authorized to be 
appropriated under subsection (a), there is authorized to 
be appropriated $2,000,000 for the maintenance and ex-
pansion of emergency contingency response capabilities 
under section 379(b)(1)(C).’’. 
(e) CONFORMING AMENDMENTS.—Part I of title III 
of the Public Health Service Act (42 U.S.C. 274k et seq.) 
is amended— 
(1) in the title heading, by striking ‘‘NA-
TIONAL BONE MARROW DONOR REG-
HR 2520 RDS 
ISTRY’’ and inserting ‘‘C.W. BILL YOUNG 
CELL TRANSPLANTATION PROGRAM’’; 
and 
(2) in section 379, as amended by this sec-
tion— 
(A) in subsection (a), by striking the term 
‘‘board’’ each place such term appears and in-
serting ‘‘Advisory Council’’; 
(B) in subection (c)— 
(i) in the matter preceding subpara-
graph (A) in paragraph (1), by striking 
‘‘Such program’’ and inserting ‘‘Such re-
cruitment program’’; 
(ii) in paragraph (2), by striking 
‘‘program under paragraph (1)’’ and in-
serting ‘‘recruitment program under para-
graph (1)’’; and 
(iii) in paragraph (3), by striking 
‘‘program under paragraph (1)’’ and in-
serting ‘‘recruitment program under para-
graph (1)’’; 
(C) in subsection (d)(2)(E), by striking 
‘‘Registry program’’ and inserting ‘‘Program’’; 
(D) in subsection (e)—
HR 2520 RDS 
(i) in the matter preceding paragraph 
(1), by striking ‘‘participating in the pro-
gram, including the Registry,’’ and insert-
ing ‘‘participating in the Program, includ-
ing’’; and 
(ii) in paragraph (6), by striking ‘‘the 
program’’ and inserting ‘‘the Program’’; 
and 
(E) by striking the term ‘‘Registry’’ each 
place such term appears and inserting ‘‘Pro-
gram’’. 
Passed the House of Representatives May 24, 2005. 
Attest: 
JEFF TRANDAHL, 
Clerk.